NCT04459988View on ClinicalTrials.gov

Mechanistic Study of Ocrevus

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

October 25, 2022

Study Completion Date

October 25, 2022

Conditions
Multiple Sclerosis
Interventions
DRUG

Ocrelizumab

Description Needed

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT04459988 - Mechanistic Study of Ocrevus | Biotech Hunter | Biotech Hunter